US Patent 9243021 Galactoside inhibitor of galectins

Patent 9243021 was granted and assigned to Galecto Biotech on January, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Galecto Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

92430210

Patent Inventor Names

Hakon Leffler0

Alison Mackinnon0

Tariq Sethi0

Ulf Nilsson0

Date of Patent

January 26, 2016

Patent Application Number

138326720

Date Filed

March 15, 2013

Patent Citations Received

‌

US Patent 11873317 Galectin-3 inhibiting c-glycosides

Patent Primary Examiner

‌

Traviss C Mcintosh, III

Patent abstract

The present invention relates to a compound of the general formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9243021 Galactoside inhibitor of galectins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API